ProQR Therapeutics BV (PRQR) — Free Cash Flow Generation Index

Latest as of March 2023: 1.00x

ProQR Therapeutics BV (PRQR) has a Free Cash Flow Generation Index of 1.00x as of March 2023. Free cash flow of $44.59 Million represents 1% of operating cash flow ($44.73 Million). See PRQR working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$44.59 Million
USD

Operating Cash Flow

$44.73 Million
USD

Capital Expenditures

$136.00K
USD

ProQR Therapeutics BV Free Cash Flow Generation Index (2023–2023)

Historical FCF Generation Index trend for ProQR Therapeutics BV across 1 annual periods. Explore PRQR operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for ProQR Therapeutics BV (2023–2023)

Year-by-year Free Cash Flow Generation Index for ProQR Therapeutics BV. For the full company profile including market capitalisation, see ProQR Therapeutics BV stock valuation.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2023 0.94x $20.18 Million $21.55 Million $1.37 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).